Amy C. Peterson Insider Trading $CTMX CytomX Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Amy C. Peterson.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Amy C. Peterson. Amy C. Peterson is EVP, Chief Development Officer in CytomX Therapeutics, Inc. ($CTMX) and CMO, Immuno-oncology in BeiGene, Ltd. ($BGNE).

Amy C. Peterson in CytomX Therapeutics, Inc.

Trading Symbol: CTMX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amy C. Peterson: EVP, Chief Development Officer
Holdings: 3,101 shares
Current Value: $35,662
Latest Transaction: Mar 02 2021
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Amy C. Peterson in CytomX Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BGNE, CTMX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 02 2021CTMXCytomX Therapeutic ...Peterson Amy C.EVP, Chief Developm ...Option ExerciseA7.85250,0001,962,500250,000
Dec 07 2020CTMXCytomX Therapeutic ...Peterson Amy C.EVP, Chief Developm ...GrantA6.393,10119,8223,1010 to 3.1 K
Feb 19 2020CTMXCytomX Therapeutic ...Peterson Amy C.EVP, Chief Developm ...Option ExerciseA7.1325,000178,25025,000
Oct 16 2019CTMXCytomX Therapeutic ...Peterson Amy C.EVP, Chief Developm ...Option ExerciseA7.16400,0002,864,000400,000

Page:   1